Antifungal Drugs: The Current Armamentarium and Development of New Agents
The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Abstract
Invasive fungal infections are becoming an increasingly important cause of human mortality and morbidity, particularly for immunocompromised populations. The fungal pathogens Candida albicans , Cryptococcus neoformans , and Aspergillus fumigatus collectively contribute to over 1 million human deaths annually. Hence, the importance of safe and effective antifungal therapeutics for the practice of modern medicine has never been greater. Given that fungi are eukaryotes like their human host, the number of unique molecular targets that can be exploited for drug development remains limited. Only three classes of molecules are currently approved for the treatment of invasive mycoses. The efficacy of these agents is compromised by host toxicity, fungistatic activity, or the emergence of drug resistance in pathogen populations. Here we describe our current arsenal of antifungals and highlight current strategies that are being employed to improve the therapeutic safety and efficacy of these drugs. We discuss state-of-the-art approaches to discover novel chemical matter with antifungal activity and highlight some of the most promising new targets for antifungal drug development. We feature the benefits of combination therapy as a strategy to expand our current repertoire of antifungals and discuss the antifungal combinations that have shown the greatest potential for clinical development. Despite the paucity of new classes of antifungals that have come to market in recent years, it is clear that by leveraging innovative approaches to drug discovery and cultivating collaborations between academia and industry, there is great potential to bolster the antifungal armamentarium.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tolerance can be affected by several adjuvant drugs 12 , iron levels 26 , and genes involved in vacuolar protein sorting 19 , as well as calcium flux 14,27,28 .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [12]
In the citing paper
“The current arsenal of antifungal compounds used for the treatment of aspergillosis consists of three classes of antifungal agents, two of them targeting ergosterol, the functional fungal analogue of cholesterol and the major component specific to fungal membranes, and a third class that targets the synthesis of β1,3 glucan, the major component of the fungal cell wall (610–614) (Fig. 20).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [613]
Citations
Cites
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Functional profiling of the Saccharomyces cerevisiae genome
Giaever, G., Chu, A. M., Ni, L., Connelly, C., Riles, L., Véronneau, S., Dow, S., Lucau-Danila, A., Anderson, K., André, B., et al. (2002) · Nature · doi:10.1038/nature00935 · Cited by 4,316
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953 · cited 1×
“cerevisiae genome are essential for viability (149).”
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Hsp90 as a capacitor for morphological evolution
Rutherford, S. L., & Lindquist, S. (1998) · Nature · doi:10.1038/24550 · Cited by 2,270
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
Self-citationThe Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162 · cited 3×
“Combination therapy also has the potential to unveil myriad additional antifungal targets given that fungal biology is controlled by a highly interconnected and functionally redundant network of biological interactions (147, 148).”
Background
Research works printed but not linked: 1
- CDC. 2013. Antibiotic Resistance Threats in the United States 2013 . CDC Atlanta GA. [PubMed]
Cited by
Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Self-citationThreats Posed by the Fungal Kingdom to Humans, Wildlife, and Agriculture
Fisher, M. C., Gurr, S. J., Cuomo, C. A., Blehert, D. S., Jin, H., Stukenbrock, E. H., Stajich, J. E., Kahmann, R., Boone, C., Denning, D. W., et al. (2020) · mBio · doi:10.1128/mbio.00449-20 · Cited by 536
Self-citationMolecular Evolution of Antifungal Drug Resistance
Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441
Self-citationCyclic peptide drugs approved in the last two decades (2001–2021)
Zhang, H., & Chen, S. (2022) · RSC Chemical Biology · doi:10.1039/d1cb00154j · Cited by 319
Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
Stan, D., Enciu, A.-M., Mateescu, A. L., Ion, A. C., Brezeanu, A. C., Stan, D., & Tanase, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.723233 · Cited by 269
Antifungal Drug Resistance: An Emergent Health Threat
Vitiello, A., Ferrara, F., Boccellino, M., Ponzo, A., Cimmino, C., Comberiati, E., Zovi, A., Clemente, S., & Sabbatucci, M. (2023) · Biomedicines · doi:10.3390/biomedicines11041063 · Cited by 228
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species
Czajka, K. M., Venkataraman, K., Brabant-Kirwan, D., Santi, S. A., Verschoor, C., Appanna, V. D., Singh, R., Saunders, D. P., & Tharmalingam, S. (2023) · Cells · doi:10.3390/cells12222655 · Cited by 180
Essential Oils and Their Natural Active Compounds Presenting Antifungal Properties
D’Agostino, M., Tesse, N., Frippiat, J., Machouart, M., & Debourgogne, A. (2019) · Molecules · doi:10.3390/molecules24203713 · Cited by 179
Azizah, N. S., Irawan, B., Kusmoro, J., Safriansyah, W., Farabi, K., Oktavia, D., Doni, F., & Miranti, M. (2023) · Plants · doi:10.3390/plants12244148 · Cited by 163
Shih, P.-Y., Liao, Y.-T., Tseng, Y.-K., Deng, F.-S., & Lin, C.-H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00602 · Cited by 156
“Thus, novel promising therapeutic strategies or new antifungal agents must be developed (Brown et al., 2012; Roemer and Krysan, 2014).”
BackgroundAdvancements and challenges in antifungal therapeutic development
Puumala, E., Fallah, S., Robbins, N., & Cowen, L. E. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00142-23 · Cited by 140
Self-citationCandida albicans gains azole resistance by altering sphingolipid composition
Gao, J., Wang, H., Li, Z., Wong, A. H.-H., Wang, Y.-Z., Guo, Y., Lin, X., Zeng, G., Liu, H., Wang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06944-1 · Cited by 130
Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus
Whitesell, L., Robbins, N., Huang, D. S., McLellan, C. A., Shekhar-Guturja, T., LeBlanc, E. V., Nation, C. S., Hui, R., Hutchinson, A., Collins, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08248-w · Cited by 124
Self-citationLu, H., Hong, T., Jiang, Y., Whiteway, M. S., & Zhang, S. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114960 · Cited by 119
Fu, C., Zhang, X., Veri, A. O., Iyer, K. R., Lash, E., Xue, A., Yan, H., Revie, N. M., Wong, C. J., Lin, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26850-3 · Cited by 97
Self-citationEvolution of antifungal resistance in the environment
van Rhijn, N., & Rhodes, J. L. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02055-y · Cited by 94
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives
Branda, F., Petrosillo, N., Ceccarelli, G., Giovanetti, M., VITO, A. D., Madeddu, G., Scarpa, F., & Ciccozzi, M. (2025) · Infectious Disease Reports · doi:10.3390/idr17040091 · Cited by 84
Drug repurposing strategies in the development of potential antifungal agents
Zhang, Q., Liu, F., Zeng, M., Xin, C., Zhang, J., Mao, Y., & Song, Z. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11407-7 · Cited by 82
The high osmolarity glycerol (HOG) pathway in fungi †
Yaakoub, H., Sanchez, N. S., Ongay-Larios, L., Courdavault, V., Calenda, A., Bouchara, J.-P., Coria, R., & Papon, N. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.2011834 · Cited by 82
Francesco, M. A. D. (2023) · Pathogens · doi:10.3390/pathogens12111305 · Cited by 81
The effect of antifungal resistance development on the virulence of Candida species
Bohner, F., Papp, C., & Gácser, A. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac019 · Cited by 78
Tavakkoli, A., Johnston, T. P., & Sahebkar, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107483 · Cited by 73
Amphotericin B in the Era of New Antifungals: Where Will It Stand?
Akinosoglou, K., Rigopoulos, E. A., Papageorgiou, D., Schinas, G., Polyzou, E., Dimopoulou, E., Gogos, C. A., & Dimοpoulos, G. (2024) · Journal of Fungi · doi:10.3390/jof10040278 · Cited by 68
Borges, A. C., Lima, G. D. M. G., Nishime, T. M. C., Gontijo, A. V. L., Kostov, K. G., & Koga‐Ito, C. Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199832 · Cited by 68
Bédard, C., Pageau, A., Fijarczyk, A., Mendoza-Salido, D., Alcañiz, A. J., Després, P. C., Durand, R., Plante, S., Alexander, E. M. M., Rouleau, F. D., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02084-7 · Cited by 66
Chen, L., Zhang, L., Xie, Y., Wang, Y., Tian, X., Fang, W., Xue, X., & Wang, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115007 · Cited by 63
Yang, F., Scopel, E. F. C., Li, H., Sun, L.-L., Kawar, N., Cao, Y.-B., Jiang, Y.-Y., & Berman, J. (2023) · mBio · doi:10.1128/mbio.00227-23 · Cited by 62
Design and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors
Huang, D. S., LeBlanc, E. V., Shekhar-Guturja, T., Robbins, N., Krysan, D. J., Pizarro, J., Whitesell, L., Cowen, L. E., & Brown, L. E. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00826 · Cited by 61
Self-citationEthnomedicinal Use, Phytochemistry, and Pharmacology of Xylocarpus granatum J. Koenig
Dey, D., Quispe, C., Hossain, R., Jain, D., Khan, R. A., Janmeda, P., Islam, M. T., Suleria, H. A. R., Martorell, M., Daştan, S. D., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/8922196 · Cited by 59
Revie, N. M., Iyer, K. R., Maxson, M. E., Zhang, J., Yan, S., Fernandes, C. M., Meyer, K. J., Chen, X., Skulska, I., Fogal, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31308-1 · Cited by 57
Self-citationPassero, L. F. D., Cavallone, I. N., & Belda, W. (2021) · Journal of Immunology Research · doi:10.1155/2021/9742832 · Cited by 56
Susceptibility testing of fungi to antifungal drugs
Sanguinetti, M., & Posteraro, B. (2018) · Journal of Fungi · doi:10.3390/jof4030110 · Cited by 55
“Paralleling the relatively recent introduction of new antifungal drug classes [7] and the discovery of novel agents [8] for the treatment of invasive fungal infections, the field of antifungal susceptibility testing (AFST) has progressed tremendously in the past several years [9].”
BackgroundMore Than Just Cleaning: Ubiquitin-Mediated Proteolysis in Fungal Pathogenesis
Cao, C., & Xue, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.774613 · Cited by 55
Antifungal Polymeric Materials and Nanocomposites
Ntow‐Boahene, W., Cook, D., & Good, L. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.780328 · Cited by 55
Pais, P., Galocha, M., Viana, R., Cavalheiro, M., Pereira, D., & Teixeira, M. C. (2019) · Microbial Cell · doi:10.15698/mic2019.03.670 · Cited by 54
BET–HDAC Dual Inhibitors for Combinational Treatment of Breast Cancer and Concurrent Candidiasis
Huang, Y., Liu, N., Pan, Z., Li, Z., & Sheng, C. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01191 · Cited by 52
Update on fungal lipid biosynthesis inhibitors as antifungal agents
Vishwakarma, M., Haider, T., & Soni, V. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127517 · Cited by 51
Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response
Mercer, D. K., & O'Neil, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02177 · Cited by 50
Vera‐González, N., Bailey‐Hytholt, C. M., Langlois, L., Ribeiro, F. D. C., Santos, E. L. D. S., Junqueira, J. C., & Shukla, A. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36984 · Cited by 50
Breakpoints for the Classification of Anti‐ Candida Compounds in Antifungal Screening
Alves, D. D. N., Ferreira, A. R., Duarte, A. B. S., Melo, A. K. V., de Sousa, D. P., & de Castro, R. D. (2021) · BioMed Research International · doi:10.1155/2021/6653311 · Cited by 48
Zhu, T., Chen, X., Li, C., Tu, J., Liu, N., Xu, D., & Sheng, C. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113524 · Cited by 44
Advances in fungal chemical genomics for the discovery of new antifungal agents
Xue, A., Robbins, N., & Cowen, L. E. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14484 · Cited by 43
Self-citationEffects of Propolis on Infectious Diseases of Medical Relevance
Rivera-Yañez, N., Rivera-Yañez, C. R., Pozo‐Molina, G., Méndez-Catalá, C. F., Reyes‐Reali, J., Mendoza‐Ramos, M. I., Méndez‐Cruz, A. R., & Nieto-Yáñez, Ó. (2021) · Biology · doi:10.3390/biology10050428 · Cited by 43
Natural Polyketides Act as Promising Antifungal Agents
Wang, L., Lu, H., & Jiang, Y. (2023) · Biomolecules · doi:10.3390/biom13111572 · Cited by 42
Xie, J., Rybak, J. M., Martín‐Vicente, A., Guruceaga, X., Thorn, H. I., Nywening, A. V., Ge, W., Parker, J. E., Kelly, S. L., Rogers, P. D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48767-3 · Cited by 42
Enhanced Efflux Pump Expression in Candida Mutants Results in Decreased Manogepix Susceptibility
Liston, S. D., Whitesell, L. J., Kapoor, M., Shaw, K. J., & Cowen, L. E. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00261-20 · Cited by 42
Self-citationHarley, B. K., Quagraine, A. M., Neglo, D., Aggrey, M. O., Orman, E., Mireku-Gyimah, N. A., Amengor, C. D. K., Jato, J., Saaka, Y., & Fleischer, T. C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278096 · Cited by 42
Marcyk, P. T., LeBlanc, E. V., Kuntz, D. A., Xue, A., Ortiz, F., Trilles, R., Bengtson, S., Kenney, T. M. G., Huang, D. S., Robbins, N., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01777 · Cited by 40
Self-citationSphingolipids: Regulators of azole drug resistance and fungal pathogenicity
Song, J., Xiao, L., & Li, R. (2020) · Molecular Microbiology · doi:10.1111/mmi.14586 · Cited by 39
John, L. L. H., Thomson, D. D., Bicanic, T. A., Hoenigl, M., Brown, A. J. P., Harrison, T. S., & Bignell, E. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01645-22 · Cited by 37
Histone Acetylation/Deacetylation in Candida Albicans and their Potential as Antifungal Targets
Su, S., Li, X., Yang, X., Li, Y., Chen, X., Sun, S., & Jia, S. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0343 · Cited by 36
Viana, R., Dias, Ó., Lagoa, D., Galocha, M., Rocha, I., & Teixeira, M. C. (2020) · Journal of Fungi · doi:10.3390/jof6030171 · Cited by 36
Structure-guided approaches to targeting stress responses in human fungal pathogens
LeBlanc, E. V., Polvi, E. J., Veri, A. O., Privé, G. G., & Cowen, L. E. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.013731 · Cited by 35
Self-citationNovel Promising Antifungal Target Proteins for Conquering Invasive Fungal Infections
Zhen, C., Lu, H., & Jiang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.911322 · Cited by 35
Mount, H. O., Revie, N. M., Todd, R. T., Anstett, K., Collins, C., Costanzo, M., Boone, C., Robbins, N., Selmecki, A., & Cowen, L. E. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007319 · Cited by 34
Self-citationFang, T., Xiong, J., Wang, L., Feng, Z., Hang, S., Yu, J., Li, W., Feng, Y., Lu, H., & Jiang, Y. (2023) · Antibiotics · doi:10.3390/antibiotics12121675 · Cited by 34
Promising immunotherapeutic targets for treating candidiasis
Feng, Z., Lu, H., & Jiang, Y. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1339501 · Cited by 33
Zambom, C. R., da Fonseca, F. H., Crusca, E., da Silva, P. B., Pavan, F. R., Chorilli, M., & Garrido, S. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01667 · Cited by 33
Quiles‐Melero, I., & García‐Rodríguez, J. (2021) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2021.04.004 · Cited by 32
Gu, K., Feng, S., Zhang, X., Peng, Y., Sun, P., Liu, W., Wu, Y., Yu, Y., Liu, X., Liu, X., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117156 · Cited by 32
Tacrolimus Increases the Effectiveness of Itraconazole and Fluconazole against Sporothrix spp.
Borba-Santos, L. P., de Sá, L. F. R., Ramos, J. A., Rodrigues, A. M., Camargo, Z. P. D., Rozental, S., & Ferreira‐Pereira, A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01759 · Cited by 32
Hossain, S., Lash, E., Veri, A. O., & Cowen, L. E. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108781 · Cited by 31
“Currently, there are only three major classes of antifungals available to treat invasive fungal infections—the azoles, the echinocandins, and the polyenes—and their use is hampered by a limited spectrum of activity, host toxicity, and the emergence of drug-resistant infections (Robbins et al., 2016).”
BackgroundSelf-citationAntifungal pipeline: New tools for the treatment of mycoses
Wolfgruber, S., Salmanton‐García, J., Kuate, M. P. N., Hoenigl, M., & Brunelli, J. G. P. (2024) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2024.11.001 · Cited by 31
Antifungal Activity and Potential Action Mechanism of Allicin against Trichosporon asahii
Yang, X., Bai, S., Wu, J., Fan, Y., Zou, Y., Xia, Z., Ao, J., Chen, T., Zhang, M., & Yang, R. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00907-23 · Cited by 31
Efficacy of Voriconazole against Aspergillus fumigatus Infection Depends on Host Immune Function
Rosowski, E. E., He, J., Huisken, J., Keller, N. P., & Huttenlocher, A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00917-19 · Cited by 31
Lu, H., Li, W., Whiteway, M., Wang, H., Zhu, S., Ji, Z., Feng, Y., Yan, L., Fang, T., Li, L., et al. (2023) · mBio · doi:10.1128/mbio.02639-22 · Cited by 30
Phytochemical and biological prospection of Mimosa genus plants extracts from Brazilian northeast
Silva, S. A. D. N. M., Barros, A. B., Souza, J. M. T., Moura, A. F., de Araújo, A. R., Mendes, M. G. A., Daboit, T. C., da Silva, D. A., Araújo, A. J., & Filho, J. D. B. M. (2020) · Phytochemistry Letters · doi:10.1016/j.phytol.2020.08.010 · Cited by 30
Synthesis and Anticandidal Activity Evaluation of New Benzimidazole-Thiazole Derivatives
Kaplancıklı, Z. A., Levent, S., Osmaniye, D., Sağlık, B. N., Çevik, U. A., Kaya, B., Özkay, Y., & Ilgın, S. (2017) · Molecules · doi:10.3390/molecules22122051 · Cited by 30
Xia, J., Wang, Z., Li, T., Lu, F., Sheng, D., & Huang, W. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s351260 · Cited by 29
Borba-Santos, L. P., Vila, T. V. M., & Rozental, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240658 · Cited by 28
Target- and prodrug-based design for fungal diseases and cancer-associated fungal infections
Liu, N., Tu, J., Huang, Y., Yang, W., Wang, Q., Li, Z., & Sheng, C. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114819 · Cited by 26
The Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies
Zobi, C., & Algül, Ö. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70045 · Cited by 26
Li, B., Shen, Y., Wu, H., Wu, X., Yuan, L., & Ji, Q. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112278 · Cited by 24
Profile of GenMark’s ePlex® blood culture identification fungal pathogen panel
Maubon, D., Dard, C., Garnaud, C., & Cornet, M. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1420476 · Cited by 23
Effects of methyl oleate and microparticle-enhanced cultivation on echinocandin B fermentation titer
Niu, K., Wu, X.-P., Hu, X., Zou, S., Hu, Z., Liu, Z., & Zheng, Y. (2020) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-020-02389-3 · Cited by 23
Jenull, S., Tscherner, M., Mair, T., & Kuchler, K. (2020) · Journal of Fungi · doi:10.3390/jof6030182 · Cited by 23
Effect of Cold Atmospheric Plasma Jet Associated to Polyene Antifungals on Candida albicans Biofilms
Leite, L. D. P., de Oliveira, M. A. C., Vegian, M. R. D. C., Sampaio, A. D. G., Nishime, T. M. C., Kostov, K. G., & Koga‐Ito, C. Y. (2021) · Molecules · doi:10.3390/molecules26195815 · Cited by 23
Therapy of Non-Dermatophytic Mycoses in Animals
Elad, D. (2018) · Journal of Fungi · doi:10.3390/jof4040120 · Cited by 23
Candida auris : host interactions, antifungal drug resistance, and diagnostics
Chowdhary, A., Lionakis, M. S., & Chauhan, N. (2025) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00187-22 · Cited by 22
Reginatto, P., Bergamo, V. Z., Berlitz, S. J., Külkamp‐Guerreiro, I. C., de Andrade, S. F., & Fuentefría, A. M. (2020) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00242-z · Cited by 22
Phosphoproteomics of Aspergillus fumigatus Exposed to the Antifungal Drug Caspofungin
Mattos, E. C., Palmisano, G., & Goldman, G. H. (2020) · mSphere · doi:10.1128/msphere.00365-20 · Cited by 22
Siswina, T., Rustama, M. M., Sumiarsa, D., & Kurnia, D. (2023) · F1000Research · doi:10.12688/f1000research.125645.3 · Cited by 21
In Vitro and In Vivo Antifungal Activity of Buparvaquone against Sporothrix brasiliensis
Borba-Santos, L. P., Barreto, T. L., Vila, T. V. M., Chi, K. D., Monti, F. D. S., de Farias, M. R., Alviano, D. S., Alviano, C. S., Futuro, D. O., Ferreira, V. F., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00699-21 · Cited by 21
Ceballos-Garzón, A., Holzapfel, M., Welsch, J., & Mercer, D. K. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf040 · Cited by 20
Combatting Fungal Infections: Advances in Antifungal Polymeric Nanomaterials
Schaefer, S., Corrigan, N. A., Brunke, S., Lenardon, M. D., & Boyer, C. A. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c00866 · Cited by 19
Li, C., Jia, X., Bian, Y., Qi, D., & Wu, J. (2020) · Mycoses · doi:10.1111/myc.13182 · Cited by 19
Wu, H., Du, C., Xu, Y., Liu, L., Zhou, X., & Ji, Q. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114208 · Cited by 19
Transcriptomic meta-analysis to identify potential antifungal targets in Candida albicans
Hefny, Z. A., Ji, B., Elsemman, I. E., Nielsen, J., & Dijck, P. V. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03213-8 · Cited by 18
Garlic-Derived Quorum Sensing Inhibitors: A Novel Strategy Against Fungal Resistance
Li, N., Zhang, J., Yu, F., Ye, F., Tan, W., Hao, L., Li, S., Deng, J., & Hu, X. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s503302 · Cited by 18
Wani, M. Y., Ahmad, A., Aqlan, F. M., & Al‐Bogami, A. S. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00030 · Cited by 18
Overcoming Global Antifungal Challenges: Medical and Agricultural Aspects
Galgóczy, L. (2025) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.5c00103 · Cited by 17
Ge, X., Gao, M., He, B., Cao, N., Li, K., Liu, Y., Tang, S., Liu, K., Zhang, J., Hu, F., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121618 · Cited by 17
Gutierrez-Perez, C., Puerner, C. T. S., Jones, J. T., Vellanki, S., Vesely, E. M., Xatse, M. A., Viera, A. F. C., Olsen, C. P., Attiku, K. O., Cardinale, S. C., et al. (2024) · mBio · doi:10.1128/mbio.01166-24 · Cited by 17
Fungal Infections, Treatment and Antifungal Resistance: The Sub-Saharan African Context
Boakye-Yiadom, E., Odoom, A., Osman, A.-H., Ntim, O. K., Kotey, F. C. N., Ocansey, B. K., & Donkor, E. S. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361241297525 · Cited by 17
Artemisinin Targets Transcription Factor PDR1 and Impairs Candida glabrata Mitochondrial Function
Zhu, P., Yue, C., Zeng, X., & Chen, X. (2022) · Antioxidants · doi:10.3390/antiox11101855 · Cited by 17
Clotrimazole is highly effective in vitro against feline Sporothrix brasiliensis isolates
Gagini, T., Borba-Santos, L. P., Rodrigues, A. M., Camargo, Z. P. D., & Rozental, S. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000608 · Cited by 17
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 16
Slezina, M. P., Istomina, E. A., & Odintsova, T. I. (2019) · Sel skokhozyaistvennaya Biologiya · doi:10.15389/agrobiology.2019.1.169eng · Cited by 16
Metadata
- Authors
- Robbins, N., Wright, G. D., & Cowen, L. E.
- Affiliations
- Michael G. DeGroote Institute for Infectious Disease Research (CA)
- University of Toronto (CA)
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2016-10-14
- Volume
- 4
- Issue
- 5
- ISSN
- 2165-0497 (ISSN-L)
- OpenAlex
- W2532305189
- Cited by
- 271
- References
- 182
- Citations by year
- 2026: 24 · 2025: 46 · 2024: 46 · 2023: 45 · 2022: 22 · 2021: 29 · 2020: 27 · 2019: 17 · 2018: 10 · 2017: 5
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Microbiology Spectrum (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- antifungal agents, invasive fungal infections, antifungal resistance, Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, antifungal drug development, antifungal drug targets, combination antifungal therapy, drug toxicity, immunocompromised patients, novel antifungal agents
- MeSH terms
- Animals, Antifungal Agents, Fungi, Humans, Mycoses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.